A role of EphB4 receptor and its ligand, ephrin-B2, in erythropoiesis

被引:60
作者
Suenobu, S
Takakura, N
Inada, T
Yamada, Y
Yuasa, H
Zhang, XQ
Sakano, S
Oike, Y
Suda, T [1 ]
机构
[1] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Differentiat, Kumamoto, Japan
[2] Asahi Chem Ind Co Ltd, Cent Technol Lab, Res Dept 2, Shizuoka, Japan
关键词
D O I
10.1016/S0006-291X(02)00330-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Erythropoiesis is regulated not only by erythropoietin but also by microenvironments which are composed of transmembrane molecules. We have previously shown that a receptor tyrosine kinase EphB4 is predominantly expressed on human erythroid progenitors in bone marrow. EphB4 is expressed in approximately 45% of hematopoietic progenitor cells, which are CD34-positive and c-Kit-positive in human umbilical cord blood (hUCB). The transmembrane ligand for EphB4 or ephrin-B2 is expressed on bone marrow stromal cells and arterial endothelial cells. When such EphB4-positive hematopoietic progenitor cells were co-cultured with stromal cells which express ephrin-B2, they were immediately detached from stromal cells and differentiated to mature erythroid cells. At that time, expression of EphB4 immediately down-regulated. In contrast, on ephrin-B2 non-expressing stromal cells, they remained EphB4-positive cells and the generated number of mature erythroid cells was less than that on ephrin-B2 expressing stromal cells. Additionally, ephrin-B2 expression on endothelial cells up-regulated under hypoxic condition. Taken together, we propose that one of the molecular cues that regulate erythropoiesis is ephrin-B2 on stromal cells. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1124 / 1131
页数:8
相关论文
共 29 条
[1]  
ABBOUD MR, 1994, EXP HEMATOL, V22, P388
[2]   The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration [J].
Adams, RH ;
Diella, F ;
Hennig, S ;
Helmbacher, F ;
Deutsch, U ;
Klein, R .
CELL, 2001, 104 (01) :57-69
[3]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[4]  
[Anonymous], 1997, Cell, V90, P403
[5]   MOLECULAR-CLONING OF A LIGAND FOR THE EPH-RELATED RECEPTOR PROTEIN-TYROSINE KINASE HTK [J].
BENNETT, BD ;
ZEIGLER, FC ;
GU, QM ;
FENDLY, B ;
GODDARD, AD ;
GILLETT, N ;
MATTHEWS, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (06) :1866-1870
[6]   Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo [J].
de Bruijn, MFTR ;
Speck, NA ;
Peeters, MCE ;
Dzierzak, E .
EMBO JOURNAL, 2000, 19 (11) :2465-2474
[7]   Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow [J].
Debili, N ;
Coulombel, L ;
Croisille, L ;
Katz, A ;
Guichard, J ;
BretonGorius, J ;
Vainchenker, W .
BLOOD, 1996, 88 (04) :1284-1296
[8]   Ephrins and their Eph receptors:: multitalented directors of embryonic development [J].
Frisén, J ;
Holmberg, J ;
Barbacid, M .
EMBO JOURNAL, 1999, 18 (19) :5159-5165
[9]   Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis [J].
Gale, NW ;
Holland, SJ ;
Valenzuela, DM ;
Flenniken, A ;
Pan, L ;
Ryan, TE ;
Henkemeyer, M ;
Strebhardt, K ;
Hirai, H ;
Wilkinson, DG ;
Pawson, T ;
Davis, S ;
Yancopoulos, GD .
NEURON, 1996, 17 (01) :9-19
[10]   Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells [J].
Gale, NW ;
Baluk, P ;
Pan, L ;
Kwan, M ;
Holash, J ;
DeChiara, TM ;
McDonald, DM ;
Yancopoulos, GD .
DEVELOPMENTAL BIOLOGY, 2001, 230 (02) :151-160